Effectiveness of Using Misoprostol and Oxytocin in the Management of Post Partum Haemorrhage
DOI:
https://doi.org/10.33755/jkk.v9iSpecial%20Edition.596Keywords:
Misoprostol, Oxytocin, Post partum haemorrhageAbstract
Aims: In 2020, the WHO estimated that as many as 295,000 women died during and after pregnancy and childbirth. Ninety percent of maternal deaths are caused by complications that arise during and after delivery, including hemorrhaging. Misoprostol, a prostaglandin analogue, is useful for treating postpartum hemorrhage for a number of reasons, including its efficiency, low cost, stability in heat, user-friendliness, and low risk of adverse effects. Oxytocin is a medication frequently used to induce labor.
Methods : Quasi experimental with one group pretest-posttest design. The sample in this study were all 18 pregnant women who experienced postpartum hemorrhage at TPMB "I" in June-December 2022, the sampling technique was total sampling.
Results : The average postpartum bleeding in laboring mothers before misoprostol and oxytocin was 406.39, and it was 141.67 afterward. Misoprostol and oxytocin are beneficial in reducing postpartum hemorrhage in TPMB "I" patients from June to December 2022 (p.value 0.000).
Conclusions : There is an effectiveness of using misoprostol and oxytocin in postpartum hemorrhage. It is expected that midwives can provide services in normal delivery using misoprostol and oxytocin safely.
References
Organization WH. WHO recommendations on antenatal care for a positive pregnancy experience. World Health Organization; 2016.
El-Mekawy HS, Eldeeb AM, El-Lythy MA, El-Begawy AF. Effect of abdominal exercises versus abdominal supporting belt on post-partum abdominal efficiency and rectus separation. International Journal of Medical and Health Sciences. 2013;7(1):75–9.
Regen S, Yanuarti T. Efektifitas Penggunaan Misoprostol Dan Oksitosin Pada Penanganan Perdarahan Post Partum Di BPM Suryati Bekasi. Malahayati Nursing Journal. 2022;4(4):840–52.
Gallos I, Williams H, Price M, Pickering K, Merriel A, Tobias A, et al. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis. Health Technol Assess. 2019;23(9):1.
Gizzo S, Patrelli TS, Gangi S Di, Carrozzini M, Saccardi C, Zambon A, et al. Which uterotonic is better to prevent the postpartum hemorrhage? Latest news in terms of clinical efficacy, side effects, and contraindications: a systematic review. Reproductive Sciences. 2013;20(9):1011–9.
Smith WRP, Papadopoulou A, Thomas E, Tobias A, Price MJ, Meher S, et al. Uterotonic agents for first‐line treatment of postpartum haemorrhage: a network meta‐analysis. Cochrane Database of Systematic Reviews. 2020;(11).
Manuaba. Ilmu Kebidanan Penyakit Kandungan dan KB. Jakarta: EGC; 2013.
Prawirohardjo S. Ilmu kandungan. Jakarta: PT Bina Pustaka Sarwono Prawirohardjo. 2011;
Damayanti NA, Wulandari RD, Ridlo IA. Maternal Health Care Utilization Behavior, Local Wisdom, and Associated Factors Among Women in Urban and Rural Areas, Indonesia. Int J Womens Health. 2023;665–77.
Cunningham FG. Obstetri Williams, Vol. 2. In EGC; 2005.
Geni PL, Rachman IT, Pradjatmo H. Peran Penambahan Misoprostol pada Penatalaksanaan Aktif Kala Tiga dalam Menurunkan Perdarahan Pasca Persalinan. Jurnal Kesehatan Reproduksi. 2017;4(3):170–7.
Milhan M, Soejoenoes A, Prawitasari S. Efikasi Misoprostol Rektal Intraoperasi Seksio Cesarea Versus Oksitosin dalam Mengurangi Jumlah Perdarahan untuk Mencegah Perdarahan Post Partum. Jurnal Kesehatan Reproduksi. 2019;6(2):37–43.
Antonius Y, Hartono E, Malinta U. Perbandingan Jumlah Perdarahan dan Lama Kala III Persalinan Menggunakan Misoprostol Sublingual dengan Oksitosin Intramuskular pada Grandemultipara. JST Kesehat. 2011;1:152–7.
